MBL2 and hepatocellular carcinoma: MBL rs7096206 (dominant comparison OR = 0.59, 95% CI 0.48–0.73; over-dominant comparison OR = 1.59, 95% CI 1.28–1.97; allele comparison: OR = 0.63, 95% CI 00.53–0.76) polymorphism was found to be significantly associated with HCC in overall combined analyses.